About FDA

FDA Webinar on "Bad Ads" Program

DATE: April 28, 2011
TIME: 12:00 p.m.

To join the meeting:
https://collaboration.fda.gov/badad/

The FDA’s BadAd Project helps the Agency’s Division of Drug Marketing, Advertising, and Communications (DDMAC) monitor drug companies’ promotional messages for fair balance and truthfulness. Learn how FDA is recruiting the assistance of healthcare professionals to help end misleading drug promotions. Examples include:

  • A presentation about a prescription drug that tells the drug’s benefits but not its risks;
  • A sales representative tells a doctor a prescription drug is effective for a use not in the FDA-approved product labeling;
  • A sales representative says, “Drug X delivers results in as little as 3 days,” but does not mention that clinical trials showed most results took 12 weeks, with only few in 3 days.

FDA’s BadAd program helps protect the public. This presentation explains how.

Page Last Updated: 08/27/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.